Shaoxing Jingxin Pharmaceuticals Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is ROSUVASTATIN CALCIUM, with a corresponding US DMF Number 38939.
Remarkably, this DMF maintains an Active status since its submission on June 12, 2024, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 20, 2024, and payment made on July 31, 2024, indicating their dedication to facilitating drug approvals, Categorized as Type II